Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Chorus joins ASX 200 - now with 8 NZX-listed Kiwi firms

Monday 24 April 2017 02:07 PM

Chorus joins ASX 200, bringing to 8 the number of NZX-listed Kiwi firms in Aussie benchmark

By Jonathan Underhill

April 24 (BusinessDesk) - Chorus, whose shares have gained 40 percent in the past two years, will join the S&P/ASX 200 Index on May 2, bringing to eight the number of New Zealand companies with a primary listing on the NZX that are also on the Australian benchmark index.

Chorus will replace Duet Group, which is being acquired by an investment group, subject to a scheme of arrangement. Chorus has a market capitalisation of A$1.6 billion. Its shares have outperformed the ASX 200 in the past five years, gaining 50 percent while the index rose 35 percent. The stock rose 3 percent to $4.34 on the NZX today.

While there will be only eight NZX-listed companies on the ASX 200, the Australian stock exchange counts 50 New Zealand companies that have sought to list their shares on the Australian bourse, either through a conventional listing or an ASX foreign exempt listing, which accounts for 35 of the companies. The foreign-exempt category was introduced in 2015, making it easier for Kiwi companies to dual-list by removing requirements to meet compliance with both sets of listing rules.

They include seven New Zealand-based companies that bypassed the NZX in favour of an ASX listing that offers access to deeper pools of capital and greater liquidity, including Neuren Pharmaceuticals, which develops biopharmaceuticals to treat brain injuries and disorders, 9 Spokes International, which sells business tools for smaller companies, jetpack maker Martin Aircraft, and wifi services company Tomizone.

The ASX 200 have a market capitalisation of about A$1.67 trillion while the NZX All Capital Index has a value of about $112 billion.

(BusinessDesk)


Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.